Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/7561
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCouper, R.-
dc.contributor.authorMcPhee, A.-
dc.contributor.authorMorris, L.-
dc.date.issued2001-
dc.identifier.citationJournal of Paediatrics and Child Health, 2001; 37(3):305-308-
dc.identifier.issn1034-4810-
dc.identifier.issn1440-1754-
dc.identifier.urihttp://hdl.handle.net/2440/7561-
dc.descriptionThe definitive version is available at www.blackwell-synergy.com-
dc.description.abstractTwin girls presented with infantile cortical periostosis (Caffey's disease) at 2 and 3 weeks of age, respectively. This disorder initially involved their upper and lower limbs and resulted in fever, irritability and tenderness. X-rays showed extensive periosteal new bone formation. Multiple relapses occurred in the first year of life and during some of these relapses mandibular and clavicular involvement was noted. Prednisolone, 1 mg/kg per day, was used to treat relapses until 9 months of age. Indomethacin therapy at this age at a dose of 3 mg/kg per day allowed the cessation of prednisolone therapy and disease flares were thereafter infrequent and responsive to indomethacin.-
dc.description.statementofresponsibilityRTL Couper, A Mcphee and L Morris-
dc.language.isoen-
dc.publisherBlackwell Science Asia-
dc.source.urihttp://dx.doi.org/10.1046/j.1440-1754.2001.00633.x-
dc.subjectBone-
dc.subjectCaffey’s disease-
dc.subjectindomethacin-
dc.subjectinfantile cortical periostosis-
dc.subjectprostaglandin synthetase inhibitors-
dc.titleIndomethacin treatment of infantile cortical periostosis in twins-
dc.typeJournal article-
dc.identifier.doi10.1046/j.1440-1754.2001.00633.x-
pubs.publication-statusPublished-
dc.identifier.orcidMcPhee, A. [0000-0003-3820-5696]-
Appears in Collections:Aurora harvest 4
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.